carbamoylphosphate synthetase I; glutamate dehydrogenase; glutamine synthetase
INTRODUCTION
Ammonia fixation and detoxification is one of the characteristic functions of the mammalian liver. We have recently reviewed the regulatory mechanisms that underlie the developmental appearance of ammonia-metabolizing enzymes within the liver (Dingemanse and Lamers, 1995) . In the present survey, we focus on the spatial and temporal expression patterns of these enzymes in prenatal murine liver. Such an analysis would provide insight into (1) the sequential aspects of hepatocyte maturation and (2) the relationship between the development of a mature liver architecture and the appearance of metabolic zonation.
Ammonia metabolism is closely linked to amino acid metabolism. The finding that the three major ammoniametabolizing enzymes in liver, glutamate dehydrogenase (GDH) [EC 1.4.1.3] , carbamoylphosphate synthetase I (CPS) [EC 6.3.4.16] , and glutamine synthetase (GS) [EC 6.3.1.2], have a distinct timing for their appearance in prenatal hepatocytes suggests that their functional roles may not be closely linked. GDH is expressed in rat hepatocytes as soon as they differentiate from the embryonic foregut Moorman et al., 1990; Westenend et al., 1986) . Because this expression coincides with the development of oxidative metabolism (Shepard et al., 1970) , it is likely that GDH activity is required for deamination. In contrast, the expression of ornithine cycle enzymes in hepatocytes, including CPS, starts relatively late during rat and mouse liver development but may vary between mammalian species. In rat and mouse hepato-cytes, CPS expression is not observed until the beginning of the fetal period (Dingemanse et al., 1996; Gaasbeek Janzen et al., 1988; Moorman et al., 1990; Morris et al., 1989) . However, in hepatocytes of human embryos, the expression of this enzyme begins shortly after the liver has differentiated from the embryonic foregut van Roon et al., 1990) . These interspecies differences in the developmental appearance of ornithine cycle enzymes in the liver are probably related to the intrauterine growth rate of the embryo Meijer et al., 1990) , which occurs earlier in development in species with a slow growth rate (human) than in species with a relatively rapid growth rate (rat and mouse). Species with a rapid prenatal growth rate apparently use the available amino acids almost exclusively for protein accretion, whereas species with a slower prenatal growth rate might oxidize amino acids to a greater extent for the generation of energy. Observations in several species, including the human, indicate that the developmental appearance of hepatic GS protein is a birth-associated event Gaasbeek Janzen et al., 1987; Moorman et al., 1989b; Shiojiri et al., 1995) .
This conclusion, however, contradicts the results of Bennett et al. (1987) that GS can be demonstrated protein in sagittal sections of the liver of two ED 13 Swiss mouse embryos. A-B, C-D, and and E-F are adjacent serial sections. Dorsal is toward the top and anterior towards the right. The top panels are paramedian sections, the sections in the middle panels pass through the inferior caval vein (vci), and the sections in the lower panels pass through the portal vein (vp). Note the sparse, median distribution of CPS-positive hepatocytes and the virtual absence of staining in the caudate lobe (lc); all hepatocytes are positive for GDH. Also note that the gut (g) is negative for CPS. bd, bile duct. Bar, 200 µm. immunohistochemically in mouse hepatocytes as early as embryonic day (ED) 15. The observation that GS mRNA can already be detected in substantial quantities in the liver of early mouse (Kuo et al., 1988) and rat embryos raised additional questions concerning the generality of the conclusion that GS protein appears late in prenatal development or concerning the antisera and/or histological methods used to demonstrate the intrahepatic presence of GS. Therefore, we obtained the antiserum used by Bennett et al. from Dr. R.E. Miller (Miller et al., 1978) and compared its staining properties in mouse liver with that of the antiserum raised against pig-brain GS (Gebhardt and Mecke, 1983 ) that we previously used to study the developmental appearance of GS in rat liver .
HETEROGENEOUS DISTRIBUTION OF AMMONIA-METABOLIZING ENZYMES IN NORMAL MOUSE AND RAT LIVER
The heterogeneous distribution pattern of GS and CPS in adult mouse liver (see also Bennett et al., 1987; Kuo et al., 1988; Shiojiri et al., 1995; Smith and Campbell, 1988 ) is comparable to that in rat liver (Gaasbeek Janzen et al., 1984; Gebhardt and Mecke, 1983; Moorman et al., 1988) , in which GS occupies a 1to 2-hepatocyte-thick layer around the central (efferent) veins and CPS a complementary 9-to 12-hepatocyte-thick layer around the portal (afferent) veins. Similar to the rat , the cellular concentration of GDH is highest in hepatocytes of the pericentral zone and gradually decreases toward the portal vein.
DISTRIBUTION OF AMMONIA-METABOLIZING ENZYMES IN THE DEVELOPING MOUSE LIVER AND GUT Glutamate Dehydrogenase
As observed previously in the rat , GDH protein is expressed in all hepatocytes of the embryonic mouse liver . This mitochondrial enzyme is, therefore, an excellent marker to visualize the topographic distribution of hepatocytes in prenatal livers when hepatocytes are intermingled with numerous hematopoietic foci. At ED 19, that is, just before birth, expression of GDH protein becomes restricted to the pericentral hepatocytes (not shown). 
Glutamine Synthetase
Similar staining patterns were obtained with the Miller and the Gebhardt antisera. A comparison of the staining properties of the Miller and Gebhardt antisera is shown in Figure 5 . However, we found a notably higher degree of background staining with the Miller antiserum than with the Gebhardt antiserum. As development progressed, this background staining gradually decreased in intensity and virtually disappeared at birth. This result suggests that the Miller antiserum recognizes additional proteins or isoenzymes in prenatal mouse liver that may or may not be related to GS. Definitive proof for this would require Western blot analysis.
Regional (interlobular) heterogeneity.
A marked regional heterogeneity could be observed in the distribution of hepatocytes in which GS protein first accumulates at ED 15. In general, these GS-positive cells appear to be associated topographically with the distribution of the major branches of the hepatic veins. In particular, the hepatocytes near the intrahepatic part of the inferior caval vein were distinctive due to their local accumulation and intense staining (Fig. 6 ). These pronounced regional differences in GS protein accumulation had disappeared by ED 16 (not shown). The timing of the appearance of GS protein in the caudate lobe was not different from that elsewhere in the liver. Dorsal is toward the top and anterior toward the right. The top panels are sections that pass through the inferior caval vein (vci), and the sections in the lower panels are slightly more medial and oblique. Note the increase in the number of CPS-positive hepatocytes in the entire liver (A,C), although the caudate lobe (lc) is still less intensely stained (A). All hepatocytes are positive for GDH. Also note that the gut has now become positive for CPS. The strongest staining is observed at ED 15 (A) in the jejunum ( j) and notably less in the duodenum (d); at ED 16 (C), this difference in staining has disappeared. The staining for GDH in the gut is less intense than that for CPS. bd, bile duct; p, pancreas. Bars, 200 µm.
Intercellular (intralobular) heterogeneity. GS protein is first detected in hepatocytes at ED 15 (Fig. 6 ). The number of hepatocytes accumulating this enzyme then further increases with development (Figs. 5, 7). By ED 18, most hepatocytes are stained by the antisera (Fig.  7) . At this stage, a lobular heterogeneity in enzyme content, which is complementary to that of CPS, becomes discernable. This heterogeneity becomes gradually more pronounced so that by the end of the first postnatal week GS staining is confined to a layer of two to three hepatocytes surrounding the central veins (Fig.  7) . The establishment of the adult distribution pattern of GS is, therefore, not interrupted perinatally as with CPS (see next section).
Gut. The small intestine, the bile, and the pancreatic ducts are negative for GS during the entire prenatal period.
Carbamoylphosphate Synthetase I Regional (interlobular) heterogeneity. Similar to our previous observations in the rat , the first accumulation of CPS protein is observed mainly in hepatocytes at the center of the liver (Fig. 1) . The accumulation of the enzyme then gradually spreads toward the peripheral parts of the median and the right and left lateral lobes. By ED 17, these peripheral areas have also become positive. In contrast to the developmental appearance of CPS protein in the median and lateral lobes, the enzyme is virtually absent from the subcapsular zones of the liver, including the entire caudate lobe, until ED 16 ( Figs. 1-3 ). In addition, the development of the typical intralobular heterogeneity is delayed a few days in this lobe ( Fig. 4) .
Intercellular (intralobular) heterogeneity. CPS protein is first detected in hepatocytes at ED 13, albeit in a small number of hepatocytes that are located mainly at the center of the liver (Fig. 1 ). As with GS (see previous section), the number of hepatocytes accumulating this enzyme gradually increases during further development (Figs. 2, 3 ; compare the staining pattern of CPS with that of GDH; see also Gaasbeek Janzen et al., 1988) . By ED 16, most hepatocytes of the median and lateral lobes have become CPS positive (Fig. 3) . This maturation of the hepatocytes in a large part of the liver is marked by a decline in the cellular concentration of CPS protein in the hepatocytes surrounding the central veins (Fig. 4) , that is, by the appearance of the adult distribution pattern of the enzyme. Toward birth and during the first 2 postnatal weeks, this intercellular heterogeneity in enzyme content temporarily disappears (Figs. 7, 8 ) but is firmly reestablished at weaning, which is comparable to the situation in the rat (Gaasbeek Janzen et al., 1985). Gut. The small intestine, particularly the jejunum, is positive for CPS from ED 15 onward (Figs. 3, 4) . During the next 2 days, the duodenum and the ileum also become positive. Nevertheless, a proximal-to-distal gradient in cellular enzyme concentration remains present in the ileum. The bile and the pancreatic ducts are always negative (Fig. 3) ; thus, the junction with the duodenum becomes well demarcated.
DISTRIBUTION OF AMMONIA-METABOLIZING ENZYMES IN THE DEVELOPING RAT LIVER
AND GUT We have previously described the overall picture of the appearance of CPS and GS mRNA and protein in rat liver and gut (Gaasbeek Janzen et al., 1986 Moorman et al., 1990) . However, in these studies, the presence of a regional heterogeneity in the appearance of ammonia-metabolizing enzymes was not clearly delineated. Figure 9 shows that in rat embryonic liver, as in the mouse (see previous section), the subcapsular zones and the caudate lobe are also distinct in that the accumulation of CPS mRNA is markedly retarded. At this stage (i.e., ED 20), GS mRNA begins to accumulate in the pericentral hepatocytes.
PRENATAL REGULATION OF GLUTAMINE SYNTHETASE EXPRESSION
This survey has focused on the developmental appearance of ammonia-metabolizing enzymes in mouse liver. The major reason for this analysis was to determine whether mouse and rat differ in their developmental timing of the expression of hepatic GS protein. Previous in situ hybridization studies (Kuo et al., 1988; Moorman et al., 1990) have revealed a strong and homogeneous expression of GS mRNA in the liver of early mouse and rat embryos. Moorman et al. (1990) showed that GS mRNA is expressed in rat hepatocytes from ED 13 (comparable to ϳED 11.5 in the mouse; see Butler and Juurlink, 1987 for comparative time tables of embryonic development) onward. However, using immunohistochemistry, we could not demonstrate GS protein in rat hepatocytes until ED 20 , whereas Bennett et al., (1987) reported that mouse hepatocytes already contain immunohistochemically detectable amounts of GS at ED 15 (comparable to ϳED 16.5 in the rat). It should be noted that Kuo et al. (1988) did not study mouse embryos before this stage. Our analysis showed that GS protein starts to accumulate in mouse hepatocytes at ED 15. The same results were obtained regardless of whether the Miller or Gebhardt antiserum was used, although the Gebhardt antiserum produced a lower background in prenatal mouse liver. Our data are in agreement with those of Darnell and colleagues (Bennett et al., 1987) , but in contrast to a more recent study (Shiojiri et al., 1995) which reports that GS immunoreactivity is not observed in mouse liver until 2-3 days after birth. This discrepancy apparently depends upon the effective antigen concentration of GS and its sensitivity for the fixation protocol. Preliminary experiments (Notenboom et al., unpublished data) indeed show that addition of glacial acetic acid to the fixation medium dramatically diminishes immunohistochemical staining for GS in prenatal hepatocytes. These experiments also revealed that GS protein can be detected in rat hepatocytes at ED 17-18, that is, 2-3 days earlier than previously recognized (see Gaasbeek , provided that acetic acid is ommitted during tissue fixation. Notwithstanding, the accumulation of GS protein in fetal hepatocytes following the onset of transcription appears to be delayed in both species. Since our technique reveals steady-state levels of mRNAs and proteins, the reason for this delay can be either a poor translational efficiency or instability of the protein in the early embryonic liver (cf. our discussion in de Groot et al., 1986 de Groot et al., , 1987 . GS (A,C,E,G) and CPS (B,D,F,H) proteins in serial sections of the liver of an ED 17 (A,B) , an ED 18 (C,D), an ED 19 (i.e., perinate) (E,F) Swiss mouse fetus, and a 8-day-old postnatal mouse (i.e., neonate) (G,H). Panels A,C,E,G: Miller antiserum. vc, central vein; vp, portal vein. Bar, 200 µm.
REGIONAL DIFFERENCES IN THE ONSET OF EXPRESSION OF CARBAMOYLPHOSPHATE
SYNTHETASE I AND GLUTAMINE SYNTHETASE The asynchronous regional accumulation of CPS and GS protein within the liver is striking. Because in mouse and rat Moorman et al., 1990 ) embryonic liver the distribution pattern of CPS mRNA and protein is the same, this heterogeneity is regulated at the pretranslational and, hence, probably at the transcriptional level. The distribution pattern of GS mRNA, however, is homogeneous in mouse and rat embryonic liver (Kuo et al., 1988; suggesting that the differential accumulation of GS protein depends on a posttranscriptional level of regulation (see also de Groot et al., 1987) .
The developmental appearance of CPS protein in mouse and rat liver appears to be strictly topographical: central versus peripheral portions of the lobes and medial plus lateral lobes versus caudate lobe. In contrast, GS protein accumulation in mouse liver is initially limited to the hepatocytes surrounding the larger hepatic veins. We also observed such a distribution pattern during the prenatal accumulation of GS protein in spiny mouse liver, even though the development of the architecture of these livers is more advanced ). These regional differences in the onset of enzyme accumulation can be due to a lack of inducing factors or the presence of repressing factors. The inability to stimulate CPS expression in hepatocytes of cultured intact rat embryos by hormones and the instantaneous expression of this enzyme after hormonal stimulation of the same hepatocytes with explantation into primary culture points to the presence of repressing factor(s) rather than to a lack of inducing factor(s) in such embryos (Westenend et al., 1986) . As stated before, a posttranscriptional level of regulation must be responsible for the accumulation of GS protein.
No candidates for these presumably novel regulatory factors have been identified so far.
We have evaluated the possibility that local differences in cell-cycle kinetics are responsible for differences in gene expression or protein accumulation. However, the initial accumulation of CPS protein in embryonic hepatocytes was found to proceed independently of the position of the cell in the cell cycle (van Roon et al., 1989a) . Thus, this finding argues against a role for the cell cycle. Differences in the timing of the developmental appearance of enzymes, possibly resulting from differences in the source of the lobar perfusate [i.e., umbilical vs. portal (systemic) blood], have been described for the left and right lobes of the fetal liver (Chianale et al., 1988) . However, the caudate lobe differs from the other liver lobes in that it is supplied with blood by both these vessels (Couinaud, 1957) . Thus, the source of the blood supply also seems to be a less likely explanation for the observed regional heterogeneity in gene expression.
DEVELOPMENT OF A COMPLEMENTARY DISTRIBUTION OF CARBAMOYLPHOSPHATE SYNTHETASE I AND GLUTAMINE SYNTHETASE
In the present survey, we have found that the typical distribution of CPS and GS around the afferent and efferent vessels, respectively, develops as soon as all hepatocytes within a lobule have started to accumulate both proteins. Our in vitro studies have shown that, with hormonal stimulation the initial accumulation of hepatocyte-specific proteins occurs stochastically (van Roon et al., 1989b) . This accumulation seems to be caused by an initially discontinuous transcription of the GS (B) and GDH (C) proteins in serial sections of the liver of a 1-day-old postnatal (i.e., perinate) Swiss mouse. Note the near-homogeneous staining of hepatocytes for CPS and the pronounced heterogeneity for GS and for GDH. vc, central vein; vp, portal vein. Bar, 200 µm. responsible genes, which is no longer observed in mature hepatocytes . This condition may also exist during the initial accumulation of GS protein. Thus, the acquisition of the capacity to coordinately and simultaneously accumulate cellspecific proteins by hepatocytes indeed appears to be a distinct landmark on the pathway to maturation. Our observations suggest that the presence of such a degree of maturation is a prerequisite for the establishment of the zonal heterogeneity in enzymic phenotype, which is so characteristic of all adult mammalian livers. Transplantation studies have shown that this developmental phenomenon coincides with that of the formation of lobules, the architectural units of the liver (Notenboom et al., 1996) . Regardless, the finding of a complementary distribution of enzymes in prenatal liver, like that observed in the adult, is indicative of a prenatal initiation of hepatic involvement in ammonia metabolism.
The findings in the mouse support our previous conclusion that the development of zonal heterogeneity proceeds independently of the process of birth . This conclusion was based on a comparison of hepatic development in altricial (rat) and precocial (spiny mouse) rodents. It remains to be established as to why zonal heterogeneity of CPS is more pronounced in prenatal mouse liver than in prenatal rat liver . The question of why accumulation of CPS protein resumes perinatally in the pericentral hepatocytes of altricial species (mouse and rat) (present review; Gaasbeek Janzen et al., 1985 but not in those of a precocial species (the spiny mouse) also needs clarification. Furthermore, it is unclear as to why the periportal hepatocytes of the mammalian liver in situ never accumulate GS. We have previously ascribed the loss of the capacity of hepatocytes to express GS or CPS in response to stimulating signals to the establishment of compartments of gene expression (Lamers et al., 1989; Moorman et al., 1989a) . In this respect, the observations in the mouse support our previous conclusion that the pericentral compartment becomes established earlier than the periportal compartment .
CARBAMOYLPHOSPHATE SYNTHETASE I AND GLUTAMINE SYNTHETASE IN THE SMALL INTESTINE
The finding that CPS protein begins to accumulate in the jejunum at ED 15 of mouse development differentiates this species from the rat, in which this enzyme is first detected at ED 14 (comparable to ϳED 12.5 in the mouse), and from the human, in which the enzyme is first observed at approximately 8 weeks of gestation (comparable to ϳED 16 in the mouse). The functional consequences of this heterochrony (i.e., a different timing of the same developmental process; Gould, 1977) between species in intestinal enzyme accumulation are presently unclear. This paucity in our understanding is further stressed by the finding that CPS and GS become complementarily expressed in the fetal gut of human and rodent embryos (Moorman et al., unpublished data) . CPS is confined to the small intestine, whereas GS is found in the distal stomach with a junction between both at the intestinal boundary of the pylorus. Because of the high concentration of CPS in the prenatal enterocyte, the enzyme probably exerts an important function in the embryo, possibly in arginine metabolism.
CONCLUSION
To summarize, the present survey highlights the successive steps in the process of liver maturation, which are necessary to establish the zonal pattern of gene expression characteristic of the adult mammalian liver. After hepatocytes have acquired the capacity to express hepatocyte-specific genes during their differentiation from the embryonic foregut, the number of hepatocytes that actually accumulate these proteins gradually increases. Once all hepatocytes participate equally in enzyme accumulation, regional differences in gene expression emerge that are related to the vascular architecture of the organ and that lead to the establishment of the periportal and pericentral zones. This zonation in turn emphasizes that the hepatic lobule is a determinant rather than a reflection of the pattern of gene expression within the liver. 
